Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. Nyquist et al.
收藏Mendeley Data2020-05-14 更新2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/48v6t9r3w6
下载链接
链接失效反馈官方服务：
资源简介：
These are the uncropped western blots used in figures 3 and 4
创建时间：
2020-05-14
